Literature DB >> 6453297

Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis.

H L Nossel.   

Abstract

Thrombosis results, in part, from localized accumulation of fibrin, implying an imbalance between its rate of formation and dissolution. Astrup postulated that patency of the vascular system depended on a dynamic equilibrium between constantly active coagulation and fibrinolytic systems. Reviews of this hypothesis have concluded that neither thrombin nor plasmin proteolysis makes a major contribution to fibrinogen turnover in normal individuals and that the hypothesis of a dynamic equilibrium between clotting and lysis remains unproven. Thus, the current view is that plasmin simply serves the function of a fibrinolytic enzyme digesting fibrin in the vascular system. Here, I promote the alternative view that the relative rates of proteolysis of the B beta chain of fibrinogen by thrombin and plasmin determine the occurrence of thrombosis. This view is supported by recent data and can be used to make some readily testable predictions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453297     DOI: 10.1038/291165a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 2.  Natural anticoagulant mechanisms.

Authors:  R D Rosenberg; J S Rosenberg
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

3.  Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.

Authors:  F N Rowland; M J Donovan; P T Picciano; G D Wilner; D L Kreutzer
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

4.  Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage.

Authors:  T F Choudhri; B L Hoh; C J Prestigiacomo; J Huang; L J Kim; A M Schmidt; W Kisiel; E S Connolly; D J Pinsky
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

5.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Authors:  D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.

Authors:  Ann R Kennedy; Amit Maity; Jenine K Sanzari
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

7.  Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant.

Authors:  T Mayumi; K Nagasawa; T Inoguchi; Y Yamauchi; Y Ishii; Y Tada; F Umeda; Y Niho
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

8.  Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.

Authors:  U Scheefers-Borchel; G Müller-Berghaus; P Fuhge; R Eberle; N Heimburger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Plasminogen activation in plasma of patients with systemic lupus erythematosus.

Authors:  N Negoro; Y Kanayama; T Takeda; M Fujisawa; M Okamura; T Inoue
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

10.  Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

Authors:  M Colucci; J A Paramo; D Collen
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.